PharmacoEconomics & Outcomes News

, Volume 807, Issue 1, pp 21–21 | Cite as

Liposomal amphotericin B cost saving in invasive fungal infections

Clinical study


  1. Neoh CF, et al. Economic evaluation of micafungin versus liposomal amphotericin B (LAmB) for treating patients with candidaemia and invasive candidiasis (IC) in Turkey. European Journal of Clinical Microbiology and Infectious Diseases : 30 Jun 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations